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Background:  It is not well known whether improvement of mitral regurgitation (MR) after CRT affects ventricular arrhythmic events (VAE).
Methods:  We investigated 499 patients (pts) from CUBIC study. (age 69+/-11years, NYHA class 2.9+/-0.6, LVEF 28+/-9%, LVEDD 62+/-9mm, 
MR grade 1.4+/0.6, QRS duration 150+/-37ms, CRT-D 58%) and divided into three groups, 361 pts with none or mild MR before CRT (MR- group), 
84 pts with moderate or severe MR and improvement of MR (MR+/improve+ group) and 54 pts with moderate or severe MR without improvement 
(MR+/improve- group). Improvement of MR was defined as MR decreased at least 0.5 grade.
Results:  After mean follow up 22+/15 months, event free survival rate from combined VF, SCD and ICD therapy for VF was significantly lower in 
MR+/improve- group compared to MR- group (79% vs. 95% at 3-year, Log-rank p=0.0012). Event free survival rate from combined VT and ICD 
therapy for VT was also significantly lower in MR+/improve- group compared to MR- group (62% vs. 86% at 3-year, Log-rank p=0.0005). However, 
event free survival rate from combined VF, SCD and ICD therapy for VF or combined VT and ICD therapy for VT were not significantly different between 
MR+/improve+ group and MR- group (92% vs. 95% at 3-year, Log-rank p=ns and 82% vs. 86% at 3-year, Log-rank p=ns, respectively).
Conclusion: Pts with moderate or severe MR without improvement of MR had higher VAE compared to none or mild MR pts. However, pts with 
moderate or severe MR with improvement had similar VAE like none or mild MR pts. 
